LOWERY THOMAS J. (Chief Scientific Officer) sold 13.6% of their position (2.20K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $9.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/8/2018ACC: 0000899243-18-015716
Officer· Chief Scientific Officer
Since Jul 2018
+8.86K
Net shares
Net buyer
$54.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.37K acquired · 7.51K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.20K
Price / share
$4.28
Trade value
$9.42K
% of position
13.6%
2/9/2018
16.24K→14.04K
Common Stock
Direct
Shares
+16.37K
Price / share
—
Trade value
—
% of position
116.6%
6/6/2018
14.04K→30.41K
Common Stock
Direct
Shares
−5.31K
Price / share
$8.53
Trade value
$45.31K
% of position
17.5%
6/6/2018
30.41K→25.10K
Total
Net shares
+8.86K
Net value
-$54.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2018 | S · Sale | −2.20K | $4.28 | $9.42K | 13.6% | 16.24K | 14.04K |
| Common Stock Direct | 6/6/2018 | A · Award | +16.37K | — | — | 116.6% | 14.04K | 30.41K |
| Common Stock Direct | 6/6/2018 | F · Tax Withholding | −5.31K | $8.53 | $45.31K | 17.5% | 30.41K | 25.10K |
| Total | +8.86K | -$54.74K | ||||||
Derivative Transactions0
No derivative transactions reported